- 4-Week # shares sold: 16,489
- 12-Week # shares sold: 26,489
- 24-Week # shares sold: 26,489
DaVita's (DVA) stock rating was reduced to 'neutral' from 'buy' at BofA/Merrill on Tuesday.
Here are Tuesday's top research calls, including an upgrade for Gilead Sciences, downgrades for Biogen and VF Corp., and new coverage for CBS.